UBS Group Lowers Walgreens Boots Alliance (NASDAQ:WBA) Price Target to $12.00

Walgreens Boots Alliance (NASDAQ:WBA) had its price objective dropped by UBS Group from $17.00 to $12.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has a “neutral” rating on the pharmacy operator’s stock. UBS Group’s target price suggests a potential upside of 8.11% from the company’s previous close.

A number of other analysts have also recently weighed in on WBA. JPMorgan Chase & Co. decreased their price target on shares of Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating for the company in a research note on Monday. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research note on Friday, June 28th. Royal Bank of Canada decreased their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday. Finally, SVB Leerink decreased their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $17.71.

Walgreens Boots Alliance Trading Down 4.1 %

Shares of NASDAQ:WBA opened at $11.10 on Wednesday. Walgreens Boots Alliance has a 52 week low of $11.10 and a 52 week high of $31.32. The company’s 50 day moving average is $16.10 and its two-hundred day moving average is $19.89. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The company has a market cap of $9.58 billion, a PE ratio of -1.65, a P/E/G ratio of 0.81 and a beta of 0.72.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The company had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company’s quarterly revenue was up 2.8% on a year-over-year basis. During the same period last year, the business earned $1.00 earnings per share. Equities analysts predict that Walgreens Boots Alliance will post 2.87 earnings per share for the current fiscal year.

Insider Transactions at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 17.40% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Quadrant Capital Group LLC raised its stake in shares of Walgreens Boots Alliance by 33.8% during the fourth quarter. Quadrant Capital Group LLC now owns 7,494 shares of the pharmacy operator’s stock valued at $196,000 after purchasing an additional 1,893 shares during the period. Syon Capital LLC purchased a new position in Walgreens Boots Alliance in the 4th quarter valued at about $333,000. New York Life Investment Management LLC boosted its position in Walgreens Boots Alliance by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 115,196 shares of the pharmacy operator’s stock valued at $3,008,000 after buying an additional 690 shares during the last quarter. EP Wealth Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at about $297,000. Finally, Corient Private Wealth LLC increased its position in shares of Walgreens Boots Alliance by 38.9% during the fourth quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock worth $7,325,000 after acquiring an additional 78,523 shares during the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.